JP2016535762A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016535762A5 JP2016535762A5 JP2016544345A JP2016544345A JP2016535762A5 JP 2016535762 A5 JP2016535762 A5 JP 2016535762A5 JP 2016544345 A JP2016544345 A JP 2016544345A JP 2016544345 A JP2016544345 A JP 2016544345A JP 2016535762 A5 JP2016535762 A5 JP 2016535762A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- potato polysaccharide
- potato
- mammal
- polysaccharide preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 62
- 244000061456 Solanum tuberosum Species 0.000 claims description 62
- 150000004676 glycans Chemical class 0.000 claims description 58
- 229920001282 polysaccharide Polymers 0.000 claims description 58
- 239000005017 polysaccharide Substances 0.000 claims description 58
- 241000124008 Mammalia Species 0.000 claims description 21
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 6
- 230000037396 body weight Effects 0.000 claims description 5
- 206010012601 diabetes mellitus Diseases 0.000 claims description 5
- 208000010706 fatty liver disease Diseases 0.000 claims description 5
- 235000012015 potatoes Nutrition 0.000 claims description 4
- 208000024891 symptom Diseases 0.000 claims description 4
- 229940087168 alpha tocopherol Drugs 0.000 claims description 3
- 235000019136 lipoic acid Nutrition 0.000 claims description 3
- 229960002663 thioctic acid Drugs 0.000 claims description 3
- 229960000984 tocofersolan Drugs 0.000 claims description 3
- 235000004835 α-tocopherol Nutrition 0.000 claims description 3
- 239000002076 α-tocopherol Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 30
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361879992P | 2013-09-19 | 2013-09-19 | |
| US61/879,992 | 2013-09-19 | ||
| PCT/US2014/053443 WO2015041837A1 (en) | 2013-09-19 | 2014-08-29 | Methods and materials for treating diabetes or liver steatosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016535762A JP2016535762A (ja) | 2016-11-17 |
| JP2016535762A5 true JP2016535762A5 (OSRAM) | 2017-09-14 |
| JP6535013B2 JP6535013B2 (ja) | 2019-06-26 |
Family
ID=52689269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016544345A Expired - Fee Related JP6535013B2 (ja) | 2013-09-19 | 2014-08-29 | 糖尿病または肝臓脂肪症を処置する方法および物質 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11160825B2 (OSRAM) |
| EP (1) | EP3046566B1 (OSRAM) |
| JP (1) | JP6535013B2 (OSRAM) |
| AU (1) | AU2014321711B2 (OSRAM) |
| CA (1) | CA2924597A1 (OSRAM) |
| WO (1) | WO2015041837A1 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016160594A1 (en) | 2015-03-27 | 2016-10-06 | The Research Foundation For The State University Of New York | Methods and materials for reducing amyloid beta levels within a mammal |
| WO2016160590A1 (en) * | 2015-03-27 | 2016-10-06 | The Research Foundation For The State University Of New York | Methods and materials for treating cancer |
| WO2018052849A1 (en) | 2016-09-19 | 2018-03-22 | Mitogenetics, Llc | Materials and methods for producing and using mitochondrial preparations |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2134714A (en) | 1936-11-25 | 1938-11-01 | Jacob A Glassman | Saccharine-aspirin tablet |
| US3622677A (en) | 1969-07-07 | 1971-11-23 | Staley Mfg Co A E | Compressed tablets containing compacted starch as binder-disintegrant ingredient |
| JP2001511153A (ja) * | 1997-02-04 | 2001-08-07 | ブイ． コスバブ，ジョン | 血管変性性疾患の予防および処置のための組成物および方法 |
| US20050085498A1 (en) * | 1998-05-28 | 2005-04-21 | Byrd Edward A. | Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate |
| US6376549B1 (en) * | 1998-09-17 | 2002-04-23 | Akesis Pharmaceuticals, Inc. | Metforimin-containing compositions for the treatment of diabetes |
| US20030159178A1 (en) | 2000-02-10 | 2003-08-21 | Peter Ulvskov | Method for remodelling cell wall polysaccharide structures in plants |
| US7590493B2 (en) | 2000-07-31 | 2009-09-15 | Ocimum Biosolutions, Inc. | Methods for determining hepatotoxins |
| DE10045059A1 (de) * | 2000-09-12 | 2002-03-21 | Basf Ag | Therapeutische Kombination von Liponsäure und Konjuensäuren zur Behandlung diabetischer Störungen |
| WO2002032905A1 (en) | 2000-10-20 | 2002-04-25 | Ajinomoto Co.,Inc. | Medicinal compositions, dose and method for treating malaria |
| US7098239B2 (en) | 2001-06-20 | 2006-08-29 | Merck & Co., Inc | Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| GB0117767D0 (en) | 2001-07-20 | 2001-09-12 | Unilever Plc | Polymers and their synthesis |
| US20050031651A1 (en) | 2002-12-24 | 2005-02-10 | Francine Gervais | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| US20050180962A1 (en) | 2003-01-30 | 2005-08-18 | Eyal Raz | Inactivated probiotic bacteria and methods of use thereof |
| US20050214413A1 (en) | 2003-08-26 | 2005-09-29 | Mannatech, Inc. | Methods and compositions for modified release of nutritional supplements |
| US20050053664A1 (en) | 2003-09-08 | 2005-03-10 | Eliezer Zomer | Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
| JP3998695B2 (ja) * | 2005-04-22 | 2007-10-31 | 株式会社シクロケム | αリポ酸水溶液及びその製造方法 |
| WO2006114019A1 (en) | 2005-04-26 | 2006-11-02 | Versitech Limited | Polysaccharide extract from lycium barbarum as neuroprotective agent against beta-amyloid peptide neurotoxicity |
| US7560536B2 (en) | 2005-05-18 | 2009-07-14 | Virginia Tech Intellectual Properties, Inc. | Morning glory-derived anticancer agents, and novel ipomoeassin compounds |
| JP4863204B2 (ja) * | 2005-06-15 | 2012-01-25 | 独立行政法人産業技術総合研究所 | 腎症関連疾患の診断方法及び診断キット |
| KR20070016520A (ko) * | 2005-08-04 | 2007-02-08 | 박옥순 | 황기청국장분말을 이용한 건강식품 |
| JP5247012B2 (ja) * | 2006-07-25 | 2013-07-24 | 雪印メグミルク株式会社 | 脂肪肝抑制剤 |
| NZ577427A (en) * | 2007-01-18 | 2011-09-30 | Novozymes As | Method for producing potato products using debranching enzymes pullulanase and isoamylase |
| JP2009007309A (ja) * | 2007-06-29 | 2009-01-15 | Riken Vitamin Co Ltd | α−リポ酸含有多芯型マイクロカプセル |
| KR101121543B1 (ko) | 2007-07-04 | 2012-03-06 | 학교법인 선목학원 | 벼과식물로부터 수득되는 전분 또는 식이섬유를 포함하는허혈성 질환 및 퇴행성 뇌질환의 예방 및 치료를 위한조성물 |
| US8569262B2 (en) | 2007-11-02 | 2013-10-29 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| JP2013506427A (ja) | 2009-10-02 | 2013-02-28 | ユニバーシティ オブ アイダホ | 強化した難消化性デンプン含有量および抑制された血糖上昇応答を有するジャガイモ製品ならびにその方法 |
| KR101093413B1 (ko) | 2009-10-05 | 2011-12-14 | 고려대학교 산학협력단 | 뇌 신경 세포 보호 활성을 갖는 고구마 추출물 및 그의 용도 |
| CN102762597A (zh) * | 2009-12-11 | 2012-10-31 | 联合利华公众股份有限公司 | 适合调节免疫应答的多糖 |
| WO2012016050A2 (en) | 2010-07-28 | 2012-02-02 | The General Hospital Corporation | Chemoradiotherapy for kras-mutant colorectal cancer |
| JP2012149004A (ja) | 2011-01-18 | 2012-08-09 | Theravalues Corp | 核内受容体の賦活剤 |
| JP6185473B2 (ja) | 2011-09-16 | 2017-08-23 | ガレクティン・セラピューティクス・インコーポレイテッドＧａｌｅｃｔｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | 非アルコール性脂肪性肝炎および非アルコール性脂肪肝疾患を処置するためのガラクト−ラムノガラクツロネート組成物 |
| CA2853799A1 (en) | 2011-11-02 | 2013-05-10 | Synta Pharmaceuticals Corp. | Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors |
| WO2013148282A1 (en) * | 2012-03-28 | 2013-10-03 | The Research Foundation Of State University Of New York | Methods and materials related to nutritional supplement compositions containing a potato polysaccharide preparation |
| US9814255B2 (en) | 2012-05-20 | 2017-11-14 | Darco Natural Products Inc. | Method for producing purple sweet potato juice and dried powder |
| US9180212B2 (en) | 2012-05-22 | 2015-11-10 | The Regents Of The University Of California | β-amyloid plaque imaging agents |
| EP2902499B1 (en) | 2012-09-28 | 2018-09-12 | BNA Inc. | Bna clamp method |
| CN103110657A (zh) | 2013-01-31 | 2013-05-22 | 黄仁彬 | 玉郎伞多糖在制备药物中的应用 |
| EP3008212A4 (en) | 2013-06-10 | 2017-05-24 | Millennium Pharmaceuticals, Inc. | Methods of treatment of cancer |
| WO2016160594A1 (en) | 2015-03-27 | 2016-10-06 | The Research Foundation For The State University Of New York | Methods and materials for reducing amyloid beta levels within a mammal |
| WO2016160590A1 (en) | 2015-03-27 | 2016-10-06 | The Research Foundation For The State University Of New York | Methods and materials for treating cancer |
| WO2017160678A1 (en) | 2016-03-14 | 2017-09-21 | Mitogenetics, Llc | Materials and methods for treating hypoxic conditions |
-
2014
- 2014-08-29 CA CA2924597A patent/CA2924597A1/en not_active Abandoned
- 2014-08-29 WO PCT/US2014/053443 patent/WO2015041837A1/en not_active Ceased
- 2014-08-29 US US15/023,069 patent/US11160825B2/en active Active
- 2014-08-29 AU AU2014321711A patent/AU2014321711B2/en not_active Ceased
- 2014-08-29 JP JP2016544345A patent/JP6535013B2/ja not_active Expired - Fee Related
- 2014-08-29 EP EP14846523.0A patent/EP3046566B1/en not_active Not-in-force
-
2021
- 2021-11-01 US US17/516,186 patent/US20220110965A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012021005A5 (OSRAM) | ||
| JP2016512248A5 (OSRAM) | ||
| JP2018527305A5 (OSRAM) | ||
| WO2011099832A3 (en) | Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same | |
| HK1204271A1 (en) | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy | |
| WO2011107749A3 (en) | Pulsatile drug release | |
| JP2010531351A5 (OSRAM) | ||
| CN108026053A8 (zh) | 作为mIDH1抑制剂的稠合的咪唑类化合物 | |
| JP2014218522A5 (OSRAM) | ||
| JP2015131825A5 (OSRAM) | ||
| JP2016510326A5 (OSRAM) | ||
| MX2013010076A (es) | Composiciones y metodos que comprenden c16:1n7 palmitoleato. | |
| RU2019110980A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
| JP2016535762A5 (OSRAM) | ||
| Cernea et al. | Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma | |
| JP2017514858A5 (OSRAM) | ||
| JP2016512247A5 (OSRAM) | ||
| JP2014513121A5 (OSRAM) | ||
| WO2012106524A3 (en) | Diagnosis and treatment of the prodromal schizophrenic state | |
| EA201590474A1 (ru) | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ КОМПОЗИТНЫХ КАПСУЛ, ВКЛЮЧАЮЩИХ ИРБЕСАРТАН И ИНГИБИТОР ГМГ-КоА РЕДУКТАЗЫ | |
| RU2017129068A (ru) | Способ лечения или профилактики атеротромботических явлений у пациентов с инфарктом миокарда в анамнезе | |
| JP2014533256A5 (OSRAM) | ||
| RU2015150303A (ru) | Композиция, содержащая гидрокортизон | |
| HK1245095A1 (zh) | 依维莫司(everolimus)与达托里昔布(dactolisib)的医药组合 | |
| WO2016122289A3 (ko) | 베르베논 유도체를 포함하는 재관류 시술의 부작용을 감소 또는 예방하기 위한 조성물 |